GlucoTrackGCTK
Market Cap: $14.5M
About: GlucoTrack Inc is a medical device company. It focuses on the design, development, and commercialization of non-invasive glucose monitoring devices for use by people with diabetes and pre-diabetics. The company has developed a non-invasive glucose monitor, the GlucoTrack model DF-F glucose monitoring device, which is designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain, inconvenience, and difficulty of conventional spot finger stick devices. It has completed a feasibility study successfully demonstrating that a minimum two-year implant life is highly probable with the sensor design. They have also initiated an animal study with an initial prototype system that has thus far demonstrated a simple implant procedure and good functionality.
Employees: 6
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
2.66% less ownership
Funds ownership: 3.2% [Q1] → 0.55% (-2.66%) [Q2]
57% less funds holding
Funds holding: 7 [Q1] → 3 (-4) [Q2]
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
78% less capital invested
Capital invested by funds: $273K [Q1] → $60.2K (-$213K) [Q2]
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Research analyst outlook
We haven’t received any recent analyst ratings for GCTK.